MARATTO

article · Scientific Reports

Photonic crystal biosensor featuring an eye-shaped cavity for precise identification of cancerous cells

Abstract

This article presents a highly sensitive and thermally stable photonic crystal (PhC) biosensor designed for accurate cancer-cell detection. The proposed sensor features a square-lattice of silicon rods (radius 0.1 µm) with a photonic bandgap spanning 1.2-2.1 µm. It includes two line-defect waveguides for input and output, and a uniquely engineered Eye-shaped cavity that holds the analyte as embedded rods. These rods are strategically arranged along the Eye-shaped boundary and the central area resembling an iris, facilitating accurate detection through resonance wavelength shifts triggered by changes in the refractive index. The biosensor demonstrates excellent transmission efficiency (69.7%-99.9%), high sensitivity (236-243 nm/RIU), and a strong quality factor (15,764-87,070), ensuring sharp and clearly defined resonance peaks. A key advantage of the design is its linear response to refractive index variations, which enhances detection accuracy and supports reliable real-time biosensing. Moreover, the sensor maintains stable performance across a wide temperature range (25 °C to 75 °C) and exhibits robust tolerance to fabrication variations. These features validate the biosensor's precision for biomedical diagnostics.

Research topics

  • Photonic Crystals and Applications
  • Photonic and Optical Devices
  • Optical Coatings and Gratings

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-025-07938-y

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.